Eight Advisory carries out the financial buyside due diligence of Inlog on behalf of Abénex

14 September 2020

‹ Back to presse releases

Eight Advisory carries out the financial buyside due diligence of Inlog on behalf of Abénex.

Abénex has mandated Eight Advisory to carry out Inlog’s financial buyside due diligence.

Inlog is a software publisher dedicated to the blood chain, from donor to transfusion. Founded in 1992, Inlog first joined Global Med Technologies in 2008, before being acquired by Haemonotics in 2010. After 10 years and a stable turnover around 7M€, the American group known for its blood collection machines and centrifuges, sold Inlog to Abénex.

The operation is an LBO which includes a senior debt. Abénex mobilizes its FPCI Croisssance, which usually injects between €5 and €20 million in capital.

Eight Advisory carried out the Financial Due Diligence buyside, the team was composed of Gennat Mouline and Julie Vuarchex.

 

 

About Eight Advisory:

Eight Advisory provides guidance to managers, investors and banks in their corporate Transactions, Reorganizations, Transformations and Financial Engineering both in France and internationally. The firm’s 440 employees, including 56 Partners, propose a financial and operational specialization dedicated to assisting managerial decision-making.

Eight Advisory is a European group, with a presence in France, the United Kingdom, Belgium, the Netherlands, Germany and Switzerland, capable of tapping, by virtue of its status as an Eight International Founding Member, into a network composed of several independent partners set up in 20 countries across Europe, the Americas, Asia and Oceania.